Work Files Saved Searches
   My Account                                                  Search:   Quick/Number   Boolean   Advanced   Derwent    Help   


 The Delphion Integrated View

  Buy Now:   Buy PDF- 17pp  PDF  |   File History  |   Other choices   
  Tools:  Citation Link  |  Add to Work File:    
  View:  Expand Details   |  INPADOC   |  Jump to: 
  Go to:  Derwent  
 Email this to a friend  Email this to a friend 
       
Title: US5464823: Mammalian antibiotic peptides
[ Derwent Title ]


Country: US United States of America

View Images High
Resolution

 Low
 Resolution

 
17 pages

 
Inventor: Lehrer, Robert I.; Santa Monica, CA
Kokryakov, Vladimir N.; Los Angeles, CA
Harwig, Sylvia S. L.; Woodland Hills, CA

Assignee: The Regents of the University of California, Oakland, CA
other patents from UNIVERSITY OF CALIFORNIA, THE REGENTS OF (599425) (approx. 4,840)
 News, Profiles, Stocks and More about this company

Published / Filed: 1995-11-07 / 1993-07-26

Application Number: US1993000095769

IPC Code: Advanced: A01N 63/02; C07K 7/08; C07K 16/18; A61K 38/00;
Core: C07K 7/00; more...
IPC-7: A61K 38/10; C07K 7/00;

ECLA Code: A01N63/02; C07K7/08A; C07K16/18;

U.S. Class: Current: 514/013; 514/012; 530/324; 530/325; 530/326;
Original: 514/013; 514/012; 530/324; 530/325; 530/326;

Field of Search: 530/326,325,324 514/013,12 536/23.5 435/69.1

Government Interest:     This invention was made with funding from NIH Grant No. A122839. The U.S. Government has certain rights in this invention.

Priority Number:
1993-07-26  US1993000095769

Abstract: Peptide-based compounds containing four invariant cysteine residues which have been oxidized to obtain two intramolecular disulfide bonds are useful as preservatives and in preventing, treating, or ameliorating viral or microbial infection in animals and plants. These compounds, in one embodiment, are of the formula:
    A1 -A2 -A3 -A4 -A5 -C-A7 -C-A9 -A10 -A11 -A12 -C-A14 -C-A16 -(A17 -A18)(1) (SEQ ID NO:4)
and the N-terminal acylated, C-terminal amidated or esterified and the cystine-bridged forms thereof
  • wherein A1, A9, A10 and A11 are basic amino acids;
  • A2 and A3 are small amino acids;
  • A5, A7, A12, A14 and A16 are hydrophobic amino acids; and
  • A4 is a basic or a small amino acid;
  • A17 is not present or, if present, is a small amino acid;
  • A18 is not present or, if present, is a basic amino acid.


Attorney, Agent or Firm: Morrison & Foerster ;

Primary / Asst. Examiners: Furman, Keith C.;

Maintenance Status: CC Certificate of Correction issued

INPADOC Legal Status: Show legal status actions          Buy Now: Family Legal Status Report

       
Related Applications: Go to Result Set: 8 patent(s) that list this one as related
Application Number Filed Patent Pub. Date  Title
US1993000093926 1993-07-20       


       
Parent Case:     This application is a continuation-in-part of U.S. Ser. No. 07/093,926 filed 20 Jul. 1993, the contents of which are incorporated herein by reference.

Designated Country: BB BG BR BY CA CN CZ FI HU KP KR KZ LK LV MG MN MW NO NZ OA PL  BE CH FR GB GR IE IT LI LU MC NL 

Family: Show 35 known family members

First Claim:
Show all 18 claims
We claim:     1. A purified and isolated compound having antimicrobial activity against E. coli, L. monocytogenes or Candida albicans, said compound being of the formula
    A1 -A2 -A3 -A4 -A5 -C-A7 -C-A9 -A10 -A11 -A12 -C-A14 -C-A16 -(A17 -A18)(1) (SEQ ID NO:4)
and the N-terminal acylated, C-terminal amidated or esterified and the cystine-bridged forms thereof
  • wherein A1, A9, A10 and A11 are basic amino acids;
  • A2 and A3 are small amino acids;
  • A5, A7, A12, A14 and A16 are hydrophobic amino acids; and
  • A4 is a basic or a small amino acid;
  • A17 is not present or, if present, is a small amino acid;
  • A18 is not present or, if present, is a basic amino acid.


Background / Summary: Show background / summary

Drawing Descriptions: Show drawing descriptions

Description: Show description

Forward References: Show 46 U.S. patent(s) that reference this one

       
U.S. References: Go to Result Set: All U.S. references   |  Forward references (46)   |   Backward references (3)   |   Citation Link

Buy
PDF
Patent  Pub.Date  Inventor Assignee   Title
Buy PDF- 10pp US4543252  1985-09 Lehrer et al.  The Regents of the University of California Cationic oligopeptides having microbicidal activity
Buy PDF- 13pp US4659692  1987-04 Lehrer et al.  The Regents of the University of California Cationic oligopeptides having microbicidal activity
Buy PDF- 16pp US4705777  1987-11 Lehrer et al.  The Regents of the University of California Cationic oligopeptides having microbicidal activity
       
Foreign References: None

Other Abstract Info: CHEMABS 122(19)230760Q CHEMABS 124(09)106630Z CHEMABS 124(09)106630Z CHEMABS 128(05)045808X CHEMABS 128(11)127091X CHEMABS 129(18)225713S CHEMABS 132(01)002807M DERABS C1995-075188

Other References:
  • Kokryakar et al., Jul. 26, 1993, FEBS 327(2):231-236. (6 pages) Cited by 19 patents [ISI abstract]
  • Robsen et al. 1986. Introduction to Protein Engineering, Elsevier, New York, p. 41.
  • Pongor, 1987, Methods in Enzymology 154:450-473. (24 pages) Cited by 25 patents
  • Nakamura et al., Tachyplesin, a Class of Antimicorbial Peptide from the Hemocytes of the Horseshoe Crab (Tachypleus tridentatus), J. Biol. Chem. (1988) 263:16709-16713. (5 pages) Cited by 28 patents
  • Miyata et al., Antimicrobial Peptides, Isolated from Horseshoe Crab Hemocytes, Tachyplesin II, and Polyphemusins I and II: Chemical Structures and Biological Activity, J. Biochem; (1989) 106:663-668. (6 pages) Cited by 18 patents
  • Murakami et al., Direct Virus Inactivation of Tachyplesin I and Its Isopeptides from Horseshoe Crab Hemocytes, Chemotherapy (1991) 37:327-334. (8 pages) Cited by 16 patents [ISI abstract]
  • Morimoto et al., Inhibitory Effect of Tachyplesin I on the Proliferation of Human Immunodeficiency Virus in vitro, Chemotherapy (1991) 37:206-211. (6 pages) Cited by 14 patents [ISI abstract]
  • Nakashima et al., Anti-Human Immunodeficiency Virus Activity of a Novel Synthetic Peptide, T22 ([Tyr-5,12,Lys-7]Polyphemusin II): a Possible Inhibitor of Virus-Cell Fusion, Antimicrobial Agents and Chemotherapy (1992) 1249-1255. (7 pages) Cited by 13 patents [ISI abstract]
  • Lehrer et al., Defensins: Endogenous Antibiotic Peptides of Animal Cells, Cell (1991) 64:229-230. (2 pages) Cited by 32 patents [ISI abstract]
  • Lehrer et al., Defensins: Antimicrobial and Cytotoxic Peptides of Mammalian Cells, Annual Review Immunol (1993) 11:105-128. (24 pages) Cited by 26 patents [ISI abstract]
  • Selsted et al., Purification, Primary Structures, and Antibacterial Activities of β-Defensins, a New Family of Antimicrobial Peptides from Bovine Neutrophils, J. Biol Chem (1993) 288:6641-6648. (8 pages) Cited by 23 patents [ISI abstract]
  • Diamond et al., Tracheal antimicrobial peptide, a cysteine-rich peptide from mammalian tracheal mucosa: Peptide isolation and cloning of a cDNA, Proc. Natl. Acad. Sci. (USA) (1991) 88:3952-3958. (5 pages) Cited by 26 patents [ISI abstract]
  • Lambert et al., Insect Immunity: Isolation from immune blood of the dipteran Phormia terranovae of two insect antibacterial peptides with sequence homology to rabbit lung macrophage bactericidal peptides, Proc. Natl. Acad. Sci. (USA) (1989) 88:262-265. (5 pages) Cited by 11 patents
  • Broekaert et al., Antimicrobial Peptides from Amaranthus caudatus Seeds with Sequence Homology tothe Cysteine/Clycine-Rich Domain o Chitin-Binding Proteins, Biochemistry (1992) 31:4308-4314. (7 pages) Cited by 22 patents [ISI abstract]
  • Cornelissen et al., Strategies for Control of Fungal Disease with Transgenic Plants, Plant Physiol (1993) 101:709-712. (4 pages) Cited by 22 patents [ISI abstract]
  • Haln et al., Disease resistance results from foreign phytoalexin expression in a novel plant, Nature (1993) 361:153-156.


  • Continuity Data:
    Application Number Filed Notes

    US2003000627829 2003-07-24  is a continuation of
    US2000000539443  2000-03-30   (abandoned)
         US20030100483A1 issued 2003-05-29   Protegrins

    US2000000539443 2000-03-30  is a continuation of
    US1998000128345  1998-08-03   (granted)
         US6159936 issued 2000-12-12   Compositions and methods for treating and preventing microbial and viral infections

    US1998000128345 1998-08-03  is a division of
    US1995000499523  1995-07-07   (granted)
         US5804558 issued 1998-09-08   Protegrins

    US1998000128345 1998-08-03  is a continuation of
    US1995000499523  1995-07-07   (granted)
         US5804558 issued 1998-09-08   Protegrins

    US1998000128345 1998-08-03  is a division of
    US1995000451832  1995-05-26   (abandoned)

    US1995000499523 1995-07-07  is a continuation in part of
    US1995000451832  1995-05-26   (abandoned)

    US1998000128345 1998-08-03  is a division of
    US1994000243879  1994-05-17   (granted)
         US5708145 issued 1998-01-13   Immunglobulins reactive with protegrins

    US1995000451832 1995-05-26  is a continuation in part of
    US1994000243879  1994-05-17   (granted)
         US5708145 issued 1998-01-13   Immunglobulins reactive with protegrins

    US1998000128345 1998-08-03  is a division of
    US1994000182483  1994-01-13   (granted)
         US5693486 issued 1997-12-02   DNA sequences encoding protegrins and protegrin analogs and their use in recombinant methods of producing protegrins

    US1994000243879 1994-05-17  is a continuation in part of
    US1994000182483  1994-01-13   (granted)
         US5693486 issued 1997-12-02   DNA sequences encoding protegrins and protegrin analogs and their use in recombinant methods of producing protegrins

    US1998000128345 1998-08-03  is a division of
    >US1993000095769<  1993-07-26   (granted)
         US5464823 issued 1995-11-07   Mammalian antibiotic peptides

    US1994000182483 1994-01-13  is a continuation in part of
    >US1993000095769<  1993-07-26   (granted)
         US5464823 issued 1995-11-07   Mammalian antibiotic peptides

    US1998000128345 1998-08-03  is a division of
    US1993000093926  1993-07-20   (abandoned)

    >US1993000095769< 1993-07-26  is a continuation in part of
    US1993000093926  1993-07-20   (abandoned)


    Inquire Regarding Licensing

    Powered by Verity


    Plaques from Patent Awards      Gallery of Obscure PatentsNominate this for the Gallery...

    Thomson Reuters Copyright © 1997-2010 Thomson Reuters 
    Subscriptions  |  Web Seminars  |  Privacy  |  Terms & Conditions  |  Site Map  |  Contact Us  |  Help